And so if you think about it, the depressing thing is that

The first of these is informed consent.

Of a drug that Dr. Bell created in '81

The material is actually being coated with the cells.

You have to go to the clinic to do it.

So, the problem is that the clinical trial was done, and we were a part of it, and in the fundamental clinical trial the pivotal clinical trial we call the Phase Three, we refused to use a placebo.

There are 170 clinical trials investigating the role of stem cells in heart disease.

We can do high frequency monitoring to get objective data.

So we know it can work.

That's about it.

They had to give it also in the U.S. to get approval, so I think there were three U.S. patients in upstate New York who were part of the trial.

There are four major conferences on building blood cell sized devices there are many experiments in animals.

Now, this is subject to a lot of debate and controversy.

In this case here, a new, wearable bio reactor has been designed it should be tested clinically later this year at ISR by Joerg Gerlach in Pittsburgh.

Now, researchers need to make every effort to ensure that an intervention that has been shown to be beneficial during a clinical trial is accessible to the participants of the trial once the trial has been completed.

I do not stand here today to suggest in any way that conducting HlV clinical trials in developing countries is bad.

(Laughter)

From the point of view of the experiencing self, clearly, B had a worse time.

There was, it turns out, a second clinical trial.

Three years ago, she entered the Novocure lung cancer trial.

As we speak, there are 117 or so clinical trials researching the use of stem cells for liver diseases.

And these devices are getting smaller and going into more and more of these patients.

The final point I would like for you to consider tonight is what happens to participants in the clinical trial once the research has been completed.

The cells genetically know what to do, and they start beating together.

It's actually scary. It's beautiful.

Examination?

I think it is absolutely wrong for research to begin in the first place without a clear plan for what would happen to the participants once the trial has ended.

So, we went back, and we've been working harder yet.

But when you start to read the article by Cliff, who himself is a cancer survivor, who was saved by a clinical trial where his parents drove him from New York City to upstate New York to get an experimental therapy for at the time Hodgkin's disease, which saved his life, he makes remarkable points here.

There's now a new research project underway at the Karolinska in Sweden to prove that hypothesis.

At this point, he was told by his doctors that he had about 3 months to live.

As part of a clinical trial for sleep disorders.

You all know about embryonic stem cells.

My diary

And so we approached this patient and asked if he would collaborate with us.

But, it turns out some component of stroke paralysis is also learned paralysis, and maybe that component can be overcome using mirrors.

Novocure conducted its first phase three randomized trial in patients with recurrent GBM.

Further clinical trials of MDMA assisted psychotherapy for PTSD are taking place around the world, and they can only be completed with your help.

So we have this bar chart here.

That confession... I'll make sure of it with the test results. Okay?

It recently came out that experts trialing drugs before they come to market typically trial drugs first, primarily on male animals and then, primarily on men.

One of the most fundamental clinical trials in cancer came out in February in the New England Journal of Medicine, where they took women who were pre menopausal with breast cancer.

Novocure's also working on lung cancer as the second target.

Midterm is blue, final is yellow.

So, in order to get you in the mood as it were